The Conversation (0)
Aurora Cannabis provided a business update to shareholders.
Aurora Cannabis (TSX:ACB; OTCQX:ACBFF) provided a business update to shareholders.
As quoted in the press release:
Continued Strong Patient Growth
As of August 28, 2017, Aurora has surpassed 19,000 active and pending registered patients less than 20 months after the Company’s first product sale in January, 2016. Aurora added approximately 3,000 patients during the months of July and August, 2017.
New Monthly Revenue and Sales Records
Aurora is on track to set a new monthly revenue record, projecting gross revenuesi for cannabis sales in Canada and Germany to exceed $3.0 million for August 2017. In Canada, the Company anticipates selling more than 275,000 grams or gram equivalents of cannabis products, and shipping approximately 15,000 orders this month. Both figures represent new highs for Aurora. Exceptional demand for the Company’s cannabis oil products has proven to be a significant revenue driver, with sales now representing approximately 26% of gross revenues.
Click here to read the full press release.
Source: www.newswire.ca
